Related Experiment Video
Updated: May 28, 2026

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection
Published on: May 7, 2020
Ibuprofen-induced aseptic meningoencephalitis confirmed by drug challenge
A Moreno-Ancillo1, A C Gil-Adrados, J Jurado-Palomo
1Department of Allergy, Hospital Nuestra Señora del Prado, Talavera de la Reina, Spain. alanaro@telefonica.net
Abstract:
Drug-induced aseptic meningitis (DIAM) is a diagnostic challenge. The major causative agents are nonsteroidal anti-inflammatory drugs (particularly ibuprofen), antibiotics, intravenous immunoglobulin, and OKT3 monoclonal antibodies. DIAM is more frequently observed in patients with autoimmune diseases. A 36-year-old woman was attended in our department 3 months after being diagnosed with aseptic meningoencephalitis. She had had 2 episodes in 9 months. Neurological symptoms were associated with ibuprofen. A challenge with acetylsalicylic acid was negative, whereas a drug challenge with ibuprofen was positive. Thirty minutes after ingesting 50 mg of ibuprofen, she experienced general malaise and progressively developed chills, fever (39.5 degrees C), headache, and nuchal rigidity. Lumbar puncture showed normal glucose and high protein levels. Neutrophilic pleocytosis was observed at the first admission; lymphocytosis was predominant in the second and third episodes. DIAM is a rare and severe hypersensitivity reaction. Drug challenge enabled us to make an accurate diagnosis.
Insights
Drug-induced aseptic meningitis (DIAM) is a rare hypersensitivity reaction, often challenging to diagnose. A case study highlights ibuprofen as a key culprit, confirmed through a positive drug challenge.
Area of Science:
- Neurology
- Immunology
- Pharmacology
Background:
- Drug-induced aseptic meningitis (DIAM) presents diagnostic challenges, with NSAIDs, antibiotics, and immunotherapies as common causes.
- DIAM is more prevalent in patients with underlying autoimmune conditions.
- Accurate diagnosis is crucial for patient management and preventing recurrence.
Observation:
- A 36-year-old woman experienced recurrent aseptic meningoencephalitis episodes over nine months.
- Neurological symptoms were consistently linked to ibuprofen use.
- A diagnostic drug challenge confirmed ibuprofen as the causative agent, triggering classic DIAM symptoms.
Findings:
- The patient presented with fever, headache, and nuchal rigidity following ibuprofen ingestion.
- Cerebrospinal fluid analysis revealed high protein levels and pleocytosis (neutrophilic initially, then lymphocytic).
- Acetylsalicylic acid challenge did not elicit a reaction, differentiating from ibuprofen's role.
Implications:
- This case underscores the importance of considering DIAM in patients with recurrent meningitis, especially those with autoimmune diseases.
- Pharmacological drug challenges are essential for confirming causative agents in suspected DIAM cases.
- Early and accurate diagnosis of DIAM prevents unnecessary investigations and guides appropriate treatment strategies.
Related Concept Videos
Bacterial Meningitis I: Introduction
Bacterial Meningitis
Bacterial Meningitis II: Pathophysiology
Encephalitis l: Introduction
Viral Meningitis
Brain Abscess l: Introduction

